Novartis AG is 52.6x more valuable than BELITE BIO, INC by market capitalization ($282.64 B vs $5.37 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BLTE | NVS |
|---|---|---|
| Market cap | $5.37 B | $282.64 B |
| US-listed rank | #1332 | #47 |
| Net income (latest FY) | -$77.61M | - |
| SEC filings | 194 | 947 |
Novartis AG is 52.6x more valuable than BELITE BIO, INC by market capitalization ($282.64 B vs $5.37 B).
Full pages: BELITE BIO, INC and Novartis AG, or browse the full rankings.